Veru
VERU
#10327
Rank
โ‚น3.61 B
Marketcap
โ‚น225.17
Share price
1.74%
Change (1 day)
-55.04%
Change (1 year)

Revenue for Veru (VERU)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of โ‚น0.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Veru from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A-100%
2024 โ‚น0.57 B-50.25%
2023 โ‚น1.14 B-49.97%
2022 โ‚น2.29 B-49.28%
2021 โ‚น4.52 B32.65%
2020 โ‚น3.41 B32.81%
2019 โ‚น2.56 B86.9%
2018 โ‚น1.37 B65.54%
2017 โ‚น0.82 B-28.74%
2016 โ‚น1.16 B-48.72%
2015 โ‚น2.27 B46.51%
2014 โ‚น1.55 B-11.14%
2013 โ‚น1.74 B-12.25%
2012 โ‚น1.98 B59.59%
2011 โ‚น1.24 B36.37%
2010 โ‚น0.91 B-28.9%
2009 โ‚น1.28 B5.88%
2008 โ‚น1.21 B48.24%
2007 โ‚น0.81 B18.35%
2006 โ‚น0.69 B16.8%
2005 โ‚น0.59 B68.19%
2004 โ‚น0.35 B-15.32%
2003 โ‚น0.41 B-3.58%
2002 โ‚น0.43 B24.57%
2001 โ‚น0.34 B28.19%
2000 โ‚น0.26 B
1998 โ‚น0.20 B49.27%
1997 โ‚น0.13 B77.62%
1996 โ‚น77.8 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น55.91 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.74 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA